Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
出版年份 2021 全文链接
标题
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-11-12
DOI
10.3389/fonc.2021.736769
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
- (2020) Po‐Han Lin et al. CANCER SCIENCE
- Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
- (2020) Qing Zhou et al. Genome Medicine
- Circulating tumor DNA is prognostic and potentially predictive of eryaspase efficacy in second-line in patients with advanced pancreatic adenocarcinoma.
- (2020) Jean-Baptiste Bachet et al. CLINICAL CANCER RESEARCH
- Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
- (2020) Edmund Lau et al. Genome Medicine
- Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
- (2020) M.J.M. Magbanua et al. ANNALS OF ONCOLOGY
- Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
- (2019) R. Charles Coombes et al. CLINICAL CANCER RESEARCH
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
- (2019) B Lee et al. ANNALS OF ONCOLOGY
- Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer
- (2019) Xianyu Zhang et al. CLINICAL CANCER RESEARCH
- Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
- (2019) Isaac Garcia-Murillas et al. JAMA Oncology
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
- (2019) Bradon R. McDonald et al. Science Translational Medicine
- Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants
- (2019) Max M. He et al. Genome Medicine
- MYC amplification in subtypes of breast cancers in African American women
- (2018) Tammey J. Naab et al. BMC CANCER
- Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays
- (2018) Catherine C. Coombs et al. CLINICAL CANCER RESEARCH
- Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
- (2018) Ryan N. Ptashkin et al. JAMA Oncology
- Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
- (2018) Babak Nami et al. Cancers
- Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
- (2017) Jian Yuan Goh et al. NATURE MEDICINE
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
- (2016) Karen Page et al. CLINICAL CHEMISTRY
- Clonal Hematopoiesis of Indeterminate Potential
- (2016) Michael Heuser et al. Deutsches Arzteblatt International
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
- (2014) F. Rothé et al. ANNALS OF ONCOLOGY
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Monitor tumor burden with circulating tumor DNA
- (2013) William D Figg II et al. CANCER BIOLOGY & THERAPY
- The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
- (2013) Carey K. Anders et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
- (2012) P. van Hagen et al. BRITISH JOURNAL OF SURGERY
- Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
- (2012) A. Narayan et al. CANCER RESEARCH
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer
- (2009) Pankaj G. Roy et al. INTERNATIONAL JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started